published meta-analysis   sensitivity analysis   studies

standard of care in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsDavoudi-Monfared, 2020 (REV) 3.28 [1.21; 8.90] 3.28[1.21; 8.90]Davoudi-Monfared, 2020 (REV)10%81NAnot evaluable deathsdetailed resultsDavoudi-Monfared, 2020 (REV) 2.67 [1.14; 6.22] 2.67[1.14; 6.22]Davoudi-Monfared, 2020 (REV)10%92NAnot evaluable deaths (time to event analysis only)detailed resultsDavoudi-Monfared, 2020 (REV) 2.67 [1.14; 6.22] 2.67[1.14; 6.22]Davoudi-Monfared, 2020 (REV)10%92NAnot evaluable clinical improvementdetailed resultsDavoudi-Monfared, 2020 (REV) 0.91 [0.53; 1.55] 0.91[0.53; 1.55]Davoudi-Monfared, 2020 (REV)10%81NAnot evaluable clinical improvement (time to event analysis only)detailed resultsDavoudi-Monfared, 2020 (REV) 0.91 [0.53; 1.55] 0.91[0.53; 1.55]Davoudi-Monfared, 2020 (REV)10%81NAnot evaluable hospital dischargedetailed resultsDavoudi-Monfared, 2020 (REV) 0.51 [0.20; 1.31] 0.51[0.20; 1.31]Davoudi-Monfared, 2020 (REV)10%81NAnot evaluable mechanical ventilationdetailed resultsDavoudi-Monfared, 2020 (REV) 1.39 [0.57; 3.40] 1.39[0.57; 3.40]Davoudi-Monfared, 2020 (REV)10%81NAnot evaluable off oxygenationdetailed resultsDavoudi-Monfared, 2020 (REV) 0.12 [0.02; 0.70] 0.12[0.02; 0.70]Davoudi-Monfared, 2020 (REV)10%32NAnot evaluable superinfectiondetailed resultsDavoudi-Monfared, 2020 (REV) 0.41 [0.13; 1.33] 0.41[0.13; 1.33]Davoudi-Monfared, 2020 (REV)10%81NAnot evaluable0.05.01.0relative treatment effectwww.metaEvidence.org2024-06-11 15:24 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 651 - roots T: 651